Tagged with R

Coronavirus Against the backdrop of an unprecedented collaborative global push to develop a COVID-19 vaccine, pharma industry executives and patient advocacy representatives at the BIO 2020 digital conference discussed the progress made towards developing a HIV vaccine and what developers of potential COVID-19 treatments and vaccines can learn from it.  …

Opinion Dr Sophia Ononye-Onyia explains why a combination of both repurposed drugs and emerging technologies like 3D bioprinting and artificial intelligence will be crucial in beating COVID-19.   Much has already been said about the hundreds of vaccines that are currently in development for providing global protection against COVID-19 by leading…

China The latest news from Chinese pharma, including the latest on Sinopharm’s COVID-19 vaccine, how geopolitical tensions are affecting trade between China and India, and the country’s latest pharma billionaire.   China’s Sinopharm touts 100 percent antibody response for COVID-19 vaccine it’s already giving to workers https://www.fiercepharma.com/pharma-asia/china-s-sinopharm-touts-100-antibody-response-for-covid-19-vaccine-it-s-already-giving Tuesday, China’s state-run Sinopharm said (Chinese)…

USA Christopher Posner, US head for Danish medical dermatology specialist LEO Pharma, outlines how a mid-sized European company navigates the US market’s complex access and affordability issues, the innovations that the company is bringing to the US, and his leadership and HR philosophy.   My priority leading LEO Pharma Inc. in…

Korea Korean biosimilar firm Celltrion’s USD 266 million acquisition of Japanese outfit Takeda assets in the Asia-Pacific region marks a significant moment in Celltrion’s international expansion as well as yet another big-money deal for Takeda.   Since Takeda’s earthshattering announcement of its intended USD 62 billion acquisition of Shire – the…

Singapore The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global crisis, the island city-state is seeing an uptick in pharmaceutical manufacturing exports to countries looking to stock up on active pharmaceutical ingredients (APIs).   Singapore’s pharmaceutical output has jumped 86 percent…

USA Two leading executives in the US generics market outline why robust company culture is key to attracting top talent that might otherwise gravitate towards the traditional research-driven industry.   Talent attraction in the US generics market could potentially become a serious problem in the next few years. Ed Price, president…

Belgium Veronique Walsh, General Manager of Bristol Myers Squibb (BMS) – Benelux, explains her ambition to build a new company culture following the acquisition of Celgene. Walsh also lays bare the prospects for bringing innovation to Belgian patients and explains how BMS continues to deliver on its promise of transforming lives…

Rankings Below we present a list of the top 5 public biopharma companies that focus on developing RNA-based therapies. RNA interference (RNAi) is a natural mechanism which is present in living cells that selectively “turns off” specific gene’s expressions, thereby affecting the production of a specific protein that contributes to disease.…

South Africa Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a call to overhaul patent laws to allow better access to COVID-19 drugs, innovation for HIV and TB medication adherence, COVID-19 vaccine trials, gut microbiome testing and supply chain lessons from the pandemic.  …

Singapore A roundup of some of the most significant healthcare and life science stories from across Singapore and the Asia-Pacific region, including the ongoing hunt for a COVID-19 vaccine and a significant acquisition for Korean Celltrion.   Coronavirus vaccine: Singapore scientists discover 5 antibodies that can combat COVID-19 https://www.businesstoday.in/sectors/pharma/coronavirus-vaccine-singapore-scientists-discover-5-antibodies-that-can-combat-covid/story/407214.html A team…

Korea Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in several global M&A deals in the past year with the end goal of finding a combination of assets that will bring value to both investors and patients. With a US manufacturing facility now…